Allina Health Names Medline as Laboratory Prime Vendor

The Minnesota-based system taps Medline for supply chain and lab portfolio solutions

Medline has entered into a multi-year prime vendor laboratory partnership with Allina Health. As the primary supplier, Medline will provide an extensive portfolio of laboratory products and solutions to Allina Health’s 15 laboratories across the system’s medical centers, hospitals, physician offices and urgent care facilities.

Allina Health first tapped Medline to support inventory challenges that emerged within its laboratory operations during the pandemic, notably the procurement of critical testing supplies when demand spiked and testing protocols rapidly changed. The two organizations worked to reallocate resources to meet demand, implement cost-saving consolidation initiatives and enhance visibility into order management, pricing and inventory accuracy throughout its supply chain. The prime vendor partnership will help to drive further efficiencies through product standardization and consolidation opportunities across the health system’s laboratory specialties.

“We were seeking a partner that could enable our comprehensive approach to drive efficiencies, implement cost savings and help establish a strong foundation for our laboratory business,” said David Wood, director of strategic sourcing and services for Allina Health. “We are excited to grow our partnership with Medline and explore future operational and capital improvement opportunities together.”

As part of the prime vendor agreement, multiple Medline team members will be dedicated to Allina Health, ensuring supply chain operational transparency and efficiency with a focus on pricing and invoice accuracy, as well as overall KPI improvements. In addition, Allina Health will have the ability to easily monitor key metrics, such as item utilization, contract compliance, price accuracy and spend by product categories, through Medline’s advanced analytics platform. The health system will also leverage Medline’s supply chain optimization solutions to support its laboratory resiliency efforts, including customized third-party logistics (3PL) capabilities to offset on-hand inventory with Medline’s inventory management services and vast warehouse network.

“Our partnership is especially unique because the Allina Health team helps us think differently,” said Megan Schwellenbach, corporate accounts vice president, acute care, for Medline. “The out-of-the-box, innovative ideas will continue to drive significant outcomes. From streamlining processes to integrating more closely with other key vendors to enhancing logistics capabilities, we’re always looking for ways to strengthen our relationship and make healthcare run better.”

Medline bridges the gap between clinical lab and supply chain efficiency, offering a broad portfolio of 120,000 products covering all major lab categories, including various Medline-branded products. Learn how Medline tailors solutions across the entire continuum of care as a manufacturer and distributor by visiting www.medline.com/supply-chain.

SourceMedline

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”